P

Inventor

GEORGES GUY

DE72 patents
⚠️ This page may combine multiple inventors who share the name “GEORGES GUY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOFFMANN LA ROCHE

39 patents
US10323089B2Jun 18, 2019

Anti-transferrin receptor antibodies with tailored affinity

HOFFMANN LA ROCHE25 citations94
US9708396B2Jul 18, 2017

Bispecific anti-VEGF/anti-ANG-2 antibodies

HOFFMANN LA ROCHE16 citations92
US6531472B2Mar 11, 2003

Tetralone derivatives

HOFFMANN LA ROCHE23 citations92
US10501521B2Dec 10, 2019

Disulfide-linked multivalent MHC class I comprising multi-function proteins

HOFFMANN LA ROCHE39 citations91
US7462639B2Dec 9, 2008

Aminopyrazole derivatives

HOFFMANN LA ROCHE46 citations91
US11584793B2Feb 21, 2023

Anti-transferrin receptor antibodies with tailored affinity

HOFFMANN LA ROCHE8 citations85
US11286300B2Mar 29, 2022

Humanized anti-human CD19 antibodies and methods of use

HOFFMANN LA ROCHE11 citations85
US10287358B2May 14, 2019

Antibodies against human CSF-1R and uses thereof

HOFFMANN LA ROCHE3 citations84
US10072087B2Sep 11, 2018

Antibodies against human CSF-1R and uses thereof

HOFFMANN LA ROCHE5 citations84
US7572809B2Aug 11, 2009

Isoquinoline aminopyrazole derivatives

HOFFMANN LA ROCHE11 citations84
US10822402B2Nov 3, 2020

Humanized anti-tau(pS422) antibodies and methods of use

HOFFMANN LA ROCHE4 citations83
US9862763B2Jan 9, 2018

Humanized anti-tau(pS422) antibodies and methods of use

HOFFMANN LA ROCHE4 citations83
US9765153B2Sep 19, 2017

Anti-biotin antibodies and methods of use

HOFFMANN LA ROCHE7 citations83
US9725512B2Aug 8, 2017

HER3 antibodies binding to the beta-hairpin of HER3

HOFFMANN LA ROCHE5 citations83
US9309319B2Apr 12, 2016

Antibodies against human IL33R and uses thereof

HOFFMANN LA ROCHE8 citations83
US11608376B2Mar 21, 2023

Tumor-targeted agonistic CD28 antigen binding molecules

HOFFMANN LA ROCHE14 citations82
US12252533B2Mar 18, 2025

Anti-transferrin receptor antibodies with tailored affinity

HOFFMANN LA ROCHE1 citations74
US11273223B2Mar 15, 2022

Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles

HOFFMANN LA ROCHE1 citations73
US10806795B2Oct 20, 2020

Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles

HOFFMANN LA ROCHE3 citations73
US10561737B2Feb 18, 2020

Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles

HOFFMANN LA ROCHE4 citations73
US9925272B2Mar 27, 2018

Anti-theophylline antibodies and methods of use

HOFFMANN LA ROCHE3 citations73
US6800638B2Oct 5, 2004

Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors

HOFFMANN LA ROCHE10 citations73
US10584178B2Mar 10, 2020

Bispecific HER2 antibodies and methods of use

HOFFMANN LA ROCHE2 citations72
US10538585B2Jan 21, 2020

Anti-ANG2 antibodies and methods of use

HOFFMANN LA ROCHE2 citations72
US10517945B2Dec 31, 2019

Covalently linked antigen-antibody conjugates

HOFFMANN LA ROCHE3 citations72
US10465000B2Nov 5, 2019

Humanized anti-Tau(pS422) antibodies and methods of use

HOFFMANN LA ROCHE2 citations72
US9562091B2Feb 7, 2017

Humanized anti-Tau(pS422) antibodies and methods of use

HOFFMANN LA ROCHE4 citations72
US10730938B2Aug 4, 2020

Bispecific antibodies and methods of use in ophthalmology

HOFFMANN LA ROCHE3 citations71
US10344085B2Jul 9, 2019

Anti-IL-1beta antibodies

HOFFMANN LA ROCHE5 citations71
US10087246B2Oct 2, 2018

Anti-PDGF-B antibodies and methods of use

HOFFMANN LA ROCHE2 citations71
US10407511B2Sep 10, 2019

Covalently linked helicar-anti-helicar antibody conjugates and uses thereof

HOFFMANN LA ROCHE2 citations70
US7226923B2Jun 5, 2007

Phthalazinone derivatives

HOFFMANN LA ROCHE8 citations70
US12297263B2May 13, 2025

Humanized anti-Tau(PS422) antibodies and methods of use

HOFFMANN LA ROCHE0 citations62
US12215152B2Feb 4, 2025

Humanized anti-human CD19 antibodies and methods of use

HOFFMANN LA ROCHE0 citations62
US11827711B2Nov 28, 2023

Antibodies binding to NKG2D

HOFFMANN LA ROCHE1 citations62
US11572404B2Feb 7, 2023

Humanized anti-Tau(pS422) antibodies and methods of use

HOFFMANN LA ROCHE0 citations62
US7235574B2Jun 26, 2007

Pentafluorosulfanyl compounds

HOFFMANN LA ROCHE6 citations62
US7091229B2Aug 15, 2006

Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors

HOFFMANN LA ROCHE4 citations62
US12227594B2Feb 18, 2025

Bispecific 2+1 contorsbodies

HOFFMANN LA ROCHE1 citations61

ROCHE GLYCART AG

4 patents

BAEHNER MONIKA

2 patents

ROCHE PALO ALTO LLC

1 patent

US HEALTH

1 patent

BRINKMANN ULRICH

1 patent

AUER JOHANNES

1 patent

BRAMLAGE BIRGIT

1 patent

Showing the top 50 of 72 patents by PatentIndex Score.